NGNE - Neurogene Stock Price
This price chart helps assess the potential of Neurogene Inc. (NGNE), a biotech startup implementing a proprietary precision gene-tuning system for brain therapy. However, Neurogene Inc. (NGNE) faces a liquidity shortage and is burning cash on R&D, with the indicator standing at 23.80. In the long term, the business is creating a unique environment for treating rare pathologies through innovative control of protein structures.
Neurogene Inc (NGNE) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- market capitalization statistics:
- book capitalization information:
- debt and liquidity data:
- company profitability and valuation multiples indicators:
NGNE - Company Net Income|Expected Profit Neurogene Inc.|NGNE - Price to Earnings Multiple|Forward P/E Multiple Neurogene|NGNE - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio Neurogene Inc|NGNE - Operating profit EBITDA|Earnings per share for the last twelve months Neurogene|NGNE - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months neurogene.com|NGNE - Earnings per share growth rate in current year|Earnings growth forecast for next year Neurogene Inc.
Analysis of all company metrics:Neurogene Inc. NGNE
To minimize investment risks, it is necessary to reconcile subjective analyst forecasts with actual market demand for the asset. This indicator captures the real-time value of the security, and market price fluctuations allow for an assessment of capital confidence in the management of Neurogene Inc. (NGNE) during the clinical trial phase of gene therapy for Rett syndrome.
Analysis of competing companies
Price Chart Biogen Inc. (BIIB)|neurocrine.com - Share Price|Stock Price RGC (Regencell Bioscience Holdings Limited)|Price Rate Chart Axsome|ACAD - Price Chart|XENE (Xenon Corp) - Share Price|VKTX: Stock Price|Market Price supernus.com (SUPN)|Price Chart Catalyst Pharmaceuticals, Inc.|Share Price DNLI (Denali)|Stock Price HRMY|BHVN - Market Price|Amylyx Pharmaceuticals - Stock Quotes|Stock Price trevitherapeutics.com TRVI|PRAX - Price Chart|Price Performance Chart AVXL (Anavex)|CeriBell Corp (CBLL) - Price Chart|Market Price Prothena Corporation plc (PRTA)|Price Chart Alector Inc.|Share Price ANNX (annexonbio.com)|Stock Price OMER|ACIU - Market Price|Voyager Pharma - Stock Quotes|Stock Price Neumora Corp NMRA|SCLX - Price Chart|Price Performance Chart TVGN (tevogen.com)|alphacognition.com (ACOG) - Price Chart|Market Price Cognition Therapeutics Inc. (CGTX)|IKT (Inhibikase) - Stock Price|SAVA - Price Rate Chart|Stock Price ASRT|COYA - Market Price|Price Chart Vistagen VTGN|OVID: Share Price|Acumen Pharma - Stock Price|Market Price CervoMed Corporation|ATHE (alteritytherapeutics.com) - Stock Quotes|Clene - Price Performance Chart|PEPG (PepGen Inc) - Stock Price|Jupiter Neurosciences, Inc. (JUNS) - Market Chart|Price Chart Relmada (RLMD)|Annovis Bio Corporation - Share Price|Stock Price GRCE (Grace Therapeutics)|AIFF - Stock Quotes|KLTO: Stock Quotes|Market Chart NeuroSense Therapeutics NRSN|Reviva Pharmaceuticals Holdings (RVPH) - Price Chart|Share Price MTVA|NRXS (NeurAxis, Inc.) - Stock Price|HSDT - Price Rate Chart|Price Chart Passage Bio, Inc. (PASG)|bionomics.com.au - Share Price|Stock Price NERV (Minerva Neurosciences Corp)|Athira Pharma Corp (ATHA) - Market Price|ADXN - Price Chart|ALZN (Alzamend Neuro, Inc.) - Share Price|CYCN: Stock Price|Market Price Protagenic Therapeutics, Inc. (PTIX)|Stock Quotes KTTA|Stock Price Cortigent Medical|Price Chart Avenue Therapeutics (ATXI)|BCLI (brainstorm-cell.com) - Price Performance Chart|Price Chart Cara Therapeutics CARA|Chromocell Therapeutics Corp (CHRO) - Market Price|ELYM - Price Chart|ITCI (Intra-Cellular Therapies) - Share Price|LBPH: Stock Price|Market Price marinuspharma.com (MRNS)|Stock Quotes NKGN|Stock Price NeuroBo Pharmaceuticals Inc|Price Chart Sage Therapeutics, Inc (SAGE)|SNPX (Synaptogenix, Inc) - Price Performance Chart|Price Chart Trevena, Inc. TRVN|Vigil Neuroscience Inc. (VIGL) - Market Price|Anew Medical - Stock Price|Price Rate Chart Cerevel Therapeutics Inc (CERE)
